Top 10 Companies in the Silicone Oil for Prefilled Syringes Market (2026): Market Leaders Powering Global Healthcare

MARKET INSIGHTS

Global silicone oil for prefilled syringes market size was valued at USD 123.5 million in 2024. The market is projected to grow from USD 129.1 million in 2025 to USD 173.4 million by 2032, exhibiting a CAGR of 3.7% during the forecast period.

Silicone oil for prefilled syringes is a specialized lubricant used to ensure smooth plunger movement in medical injection devices. This high‑purity silicone fluid reduces friction between the rubber plunger and glass barrel, maintaining drug stability while meeting stringent biocompatibility requirements. The product is available in various viscosities including 20cSt, 100cSt, 350cSt, 1000cSt, and 12500cSt formulations.

The market growth is driven by increasing adoption of biologics and biosimilars requiring specialized drug delivery systems, coupled with rising demand for self‑administration devices. However, regulatory scrutiny on silicone migration presents challenges. North America currently leads the market with a 35% revenue share, while Asia‑Pacific shows the fastest growth at 5.1% CAGR due to expanding healthcare infrastructure and local production capabilities.

Silicone Oil for Prefilled Syringes Market – View in Detailed Research Report

10️⃣ 1. Elkem

Headquarters: Norway
Key Offering: High‑purity low‑viscosity silicone oils for prefilled syringes

Elkem supplies a range of silicone fluids, including 20cSt and 100cSt grades, that meet stringent biocompatibility standards required for biologics and biosimilars. Their integrated silicon‑metal production enables economies of scale and consistent product quality.

Sustainability Initiatives:

• Investing in low‑energy polymerisation processes.
• Partnering with pharma companies to reduce silicone migration.
• Committing to carbon‑neutral operations by 2030.

9️⃣ 2. Dow

Headquarters: United States
Key Offering: Broad spectrum of silicone oils from 20cSt to 12500cSt for medical devices

Dow’s extensive R&D pipeline delivers high‑purity silicone formulations that support advanced drug delivery systems, including fixed‑nozzle and hybrid‑nozzle syringes.

Sustainability Initiatives:

• Reducing CO2 emissions in polymerisation plants.
• Developing low‑extractable silicone variants.
• Engaging in circular economy partnerships with pharma clients.

8️⃣ 3. Wacker Chemie

Headquarters: Germany
Key Offering: Comprehensive silicone fluid portfolio for prefilled syringes

Wacker’s large‑scale polymerisation plants and ISO 13485 certification ensure consistent supply of high‑purity silicone oils suitable for sterile drug delivery.

Sustainability Initiatives:

• Optimizing energy use across production sites.
• Investing in renewable energy for manufacturing.
• Supporting green chemistry initiatives.

7️⃣ 4. Momentive

Headquarters: United States
Key Offering: Advanced siloxane chemistry for tailored viscosity blends

Momentive’s proprietary siloxane chemistry allows precise control over viscosity, enabling customized solutions for both low‑ and high‑viscosity grades.

Sustainability Initiatives:

• Reducing solvent usage in formulation.
• Developing biodegradable silicone additives.
• Collaborating with pharma for low‑migration solutions.

6️⃣ 5. Shin‑Etsu Chemical

Headquarters: Japan
Key Offering: High‑performance silicone oils for medical applications

Shin‑Etsu’s advanced siloxane chemistry delivers superior biocompatibility, essential for sensitive biologic formulations.

Sustainability Initiatives:

• Implementing energy‑efficient polymerisation processes.
• Reducing water consumption in manufacturing.
• Engaging in ESG reporting and transparency.

5️⃣ 6. Gelest

Headquarters: United States
Key Offering: Specialty high‑purity silicone oils for precision drug‑delivery devices

Gelest focuses on ultra‑high‑purity formulations, catering to niche applications such as implantable drug delivery systems.

Sustainability Initiatives:

• Adopting green chemistry principles.
• Reducing hazardous waste in production.
• Partnering with research institutions on low‑migration silicone.

4️⃣ 7. Weihai HighGreen Medical

Headquarters: China
Key Offering: Cost‑effective silicone oils for the Asian market

Weihai HighGreen Medical has rapidly expanded its production capacity to serve the growing demand for compliant prefilled syringe technology in Asia‑Pacific.

Sustainability Initiatives:

• Implementing energy‑saving production lines.
• Developing low‑extractable silicone variants.
• Supporting local healthcare infrastructure projects.

3️⃣ 8. Avantor

Headquarters: United States
Key Offering: Distributor and emerging silicone formulation capabilities

Avantor supplies a wide range of laboratory chemicals and is expanding into in‑house silicone formulation to support its extensive supply chain.

Sustainability Initiatives:

• Optimizing logistics to reduce carbon footprint.
• Investing in sustainable packaging.
• Collaborating with pharma to develop low‑migration solutions.

2️⃣ 9. Dupont

Headquarters: United States
Key Offering: Innovative silicone formulations for medical devices

Dupont’s research focuses on next‑generation silicone oils that meet evolving regulatory standards for drug delivery systems.

Sustainability Initiatives:

• Reducing greenhouse gas emissions in production.
• Developing recyclable silicone packaging.
• Engaging in ESG reporting and stakeholder transparency.

1️⃣ 10. BASF

Headquarters: Germany
Key Offering: Strategic partnerships to re‑enter the medical silicone space

BASF is exploring joint ventures and collaborations to deliver high‑purity silicone oils tailored for prefilled syringes and other medical applications.

Sustainability Initiatives:

• Investing in renewable energy for manufacturing.
• Reducing waste in silicone production.
• Partnering with pharma for low‑migration solutions.

Silicone Oil for Prefilled Syringes Market – View in Detailed Research Report

Silicone Oil for Prefilled Syringes Market – View in Detailed Research Report

🌍 Outlook: The Future of Silicone Oil for Prefilled Syringes Is Smarter and Cleaner

Global demand for high‑purity silicone oils is set to accelerate as biologics and biosimilars continue to dominate the pharmaceutical landscape. The market is projected to expand from USD 129.1 million in 2025 to USD 180 million by 2034, driven by a CAGR of 3.7% and increasing adoption of self‑administration devices in both developed and emerging regions.

📈 Key Trends Shaping the Market:

• Rising demand for biologics and advanced therapies driving the need for low‑friction silicone lubricants.
• Regulatory clarity on acceptable silicone‑oil residues reducing development uncertainty.
• Innovation in low‑extractable silicone formulations for ultra‑sensitive biologics.
• Integration of silicone‑oil‑coated syringes with smart delivery platforms and digital dose‑tracking devices.
• Rapid growth in Asia‑Pacific and emerging economies, fueled by expanding healthcare infrastructure and local production capabilities.
• Strategic partnerships and joint ventures reshaping competitive dynamics and expanding product portfolios.